Skip to main content
editorial
. 2022 Jan 4;114(3):335–337. doi: 10.1093/jnci/djab211

Table 1.

Summary of recommendations for addressing medical financial hardship

Audience Recommendation
Cancer care providers Conduct routine screening with validated instruments at all visits
Document referrals for financial hardship and social needs and whether and how they are addressed
Cancer centers Require comprehensive screening throughout cancer treatment and connecting patients to services
Enhance partnerships with community safety net organizations
Advocate for health policies that benefit patients and their families
Record reasons eligible patients decline clinical trial participation and drop out prematurely
Collect information about financial hardship in clinical trials and consider inclusion in adverse event reporting
Health policy Increase options for comprehensive health insurance coverage
Implement caps on patient out-of-pocket expenses
Include financial hardship screening and connection with services as quality measures
Require assessment of patient financial hardship and social needs as part of evaluation of value-based payment models
Research and surveillance Develop validated financial hardship instruments for use at the point of care and integration in electronic health records
Collect financial information prior to diagnosis, potentially through data linkages
Evaluate interrelationship of financial hardship and social needs
Assess associations of medical financial hardship and quality of cancer care, including diagnostic and treatment delays and completion of all recommended treatment and survivorship care
Evaluate short- and long-term health effects of medical financial hardship, including health-related quality of life, cancer recurrence, and survival following diagnosis
Evaluate the economic, social, and health effects of patient medical financial hardship on family and informal caregivers
Conduct rigorous evaluation of value-based payment models to inform care delivery and health policy